Multidrug-Resistant Plasmodium falciparum Parasites in the Central Highlands of Vietnam Jeopardize Malaria Control and Elimination Strategies
Author:
Affiliation:
1. Institute of Malariology, Parasitology and Entomology, Quy Nhon, Vietnam
2. Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia
3. U.S. Naval Medical Research Unit TWO, Singapore
Abstract
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Link
https://journals.asm.org/doi/pdf/10.1128/AAC.01639-20
Reference41 articles.
1. WHO. 2001. Antimalarial drug combination therapy. Report of a technical consultation. World Health Organisation, Geneva, Switzerland.
2. WHO. 2006. Guidelines for the treatment of malaria. World Health Organization, Geneva, Switzerland.
3. Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance
4. Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance
5. Declining Artesunate-Mefloquine Efficacy against Falciparum Malaria on the Cambodia–Thailand Border
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Evaluation of Dihydroartemisinin–Piperaquine Efficacy and Molecular Markers in Uncomplicated Falciparum Patients: A Study across Binh Phuoc and Dak Nong, Vietnam;Medicina;2024-06-20
2. Dihydroartemisinin-piperaquine efficacy in Plasmodium falciparum treatment and prevalence of drug-resistant molecular markers along China-Myanmar border in 2014–2023;Journal of Global Antimicrobial Resistance;2023-12
3. Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam;Malaria Journal;2023-10-28
4. Mosquitoes and Mosquito-Borne Diseases in Vietnam;Insects;2022-11-22
5. A single point mutation in the Plasmodium falciparum 3′–5′ exonuclease does not alter piperaquine susceptibility;Malaria Journal;2022-04-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3